未登录

O

Oscar Leeuwenkamp

gartnavel royal hospital

H指数:16

被引数:1,052

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective

European Journal of Nuclear Medicine and Molecular Imaging

IF7.6

2021-12-249

OAAI

Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis (vol 93, 102141, 2021)

CANCER TREATMENT REVIEWS

IF10.5

2021-06-010

PREAI

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE

JOURNAL OF NUCLEAR MEDICINE

IF9.1

2021-03-2615

OAAI

Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis

CANCER TREATMENT REVIEWS

IF10.5

2021-02-0152

OAAI

Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland

IF3.4

2021-01-056

OAAI

Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2020-07-0710

OAAI

Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2017-11-0811

OAAI

EVALUATION OF THE CLINICAL AND ECONOMIC BURDEN OF CHRONIC CONSTIPATION IN BELGIUM

VALUE IN HEALTH

IF6

2011-11-010

OAAI

BURDEN OF PEDIATRIC INFLUENZA IN EUROPE: A GAP ANALYSIS

VALUE IN HEALTH

IF6

2009-10-010

OAAI

Humanistic and economic outcomes associated with negative symptoms in patients with schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2008-08-010

PREAI

Quality of life and resource use in patients with bipolar disorder in Europe and the USA

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2008-03-010

PREAI

Adjunctive psychosocial therapies for the treatment of schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2008-03-0186

PREAI

Costs and outcomes of atypical antipsychotics for the treatment of acute schizophrenia

VALUE IN HEALTH

IF6

2007-11-010

OAAI

Associations between negative symptoms, service use, and costs for patients with schizophrenia in five European countries

VALUE IN HEALTH

IF6

2007-11-010

OAAI

Associations between negative symptoms, service use, and costs in patients with schizophrenia in five European countries

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2007-10-010

PREAI

A multinational assessment of quality of life and resource use by bipolar disorder patients in Europe and the US

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2007-10-010

PREAI

Physician observations and perceptions of positive and negative symptoms of schizophrenia: A multinational, cross-sectional survey

EUROPEAN PSYCHIATRY

IF6.7

2007-05-2322

PREAI

Analysis of a multinational, cross-sectional survey of physician descriptions and perceptions of patients with negative symptoms of schizophrenia

VALUE IN HEALTH

IF6

2006-11-010

OAAI

Resource use among patients with schizophrenia in 5 European countries

VALUE IN HEALTH

IF6

2006-11-010

OAAI

Quality of life in patients with bipolar disorder in 5 European countries

VALUE IN HEALTH

IF6

2006-11-010

OAAI